A detailed history of Schneider Downs Wealth Management Advisors, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Schneider Downs Wealth Management Advisors, LP holds 1,494 shares of ABBV stock, worth $258,491. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,494
Previous 1,533 2.54%
Holding current value
$258,491
Previous $262,000 12.6%
% of portfolio
0.06%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$163.84 - $199.33 $6,389 - $7,773
-39 Reduced 2.54%
1,494 $295,000
Q2 2024

Aug 07, 2024

SELL
$154.79 - $180.76 $34,982 - $40,851
-226 Reduced 12.85%
1,533 $262,000
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $32,123 - $36,602
201 Added 12.9%
1,759 $320,000
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $55,040 - $61,988
-400 Reduced 20.43%
1,558 $241,000
Q4 2022

Feb 01, 2023

SELL
$138.31 - $165.87 $58,228 - $69,831
-421 Reduced 17.7%
1,958 $316,000
Q3 2022

Oct 26, 2022

SELL
$134.21 - $153.93 $76,365 - $87,586
-569 Reduced 19.3%
2,379 $319,000
Q2 2022

Jul 13, 2022

SELL
$137.62 - $174.96 $28,074 - $35,691
-204 Reduced 6.47%
2,948 $452,000
Q1 2022

May 02, 2022

BUY
$131.98 - $163.75 $2,507 - $3,111
19 Added 0.61%
3,152 $511,000
Q4 2021

Jan 31, 2022

SELL
$107.43 - $135.93 $10,743 - $13,593
-100 Reduced 3.09%
3,133 $424,000
Q3 2021

Oct 14, 2021

BUY
$106.4 - $120.78 $20,216 - $22,948
190 Added 6.24%
3,233 $349,000
Q2 2021

Jul 20, 2021

BUY
$105.21 - $117.21 $3,892 - $4,336
37 Added 1.23%
3,043 $343,000
Q1 2021

Apr 26, 2021

BUY
$102.3 - $112.62 $59,436 - $65,432
581 Added 23.96%
3,006 $325,000
Q4 2020

Jan 21, 2021

SELL
$80.49 - $108.67 $39,037 - $52,704
-485 Reduced 16.67%
2,425 $260,000
Q3 2020

Oct 14, 2020

BUY
$85.91 - $100.83 $1,202 - $1,411
14 Added 0.48%
2,910 $255,000
Q1 2020

Apr 21, 2020

BUY
$64.5 - $97.79 $186,792 - $283,199
2,896 New
2,896 $221,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $306B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Schneider Downs Wealth Management Advisors, LP Portfolio

Follow Schneider Downs Wealth Management Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schneider Downs Wealth Management Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Schneider Downs Wealth Management Advisors, LP with notifications on news.